Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-004923-39Phase 3Completed
Phase 3, single-arm trial of pelargonium sidoides extract, sponsored by Schwabe Group. Primary endpoint: Area under the curve of total rhinopharyngitis-relevant symptom score. Started Oct 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-004923-39.